The breast cancer cases with a tumor size of 21–50 mm and PR-negative status correlated with a significantly higher Oncotype DX recurrence score when compared to tumor size of 10 mm or less and PR-positive status, respectively. This evidence concerns the gene PGR and neoplasm.